Gaudium IVF IPO logo

Gaudium IVF IPO

Listed

GAUDIUMIVF

Mainboard NSE,BSE Healthcare

Gaudium IVF IPO, a Mainboard IPO was listed on the exchange on February 27, 2026. The price band is set between ₹75 –79 , with a face value of ₹5 . Retail investors can apply with a minimum of 1 lot, each comprising 189 shares — amounting to ₹14,931 at the upper price.

Gaudium IVF IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.

Gaudium IVF IPO MAINBOARD Important Dates

Get important updates regarding Gaudium IVF IPO MAINBOARD tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.

Listing Performance

Listing day gain

+5.06%

Listed at ₹83 (issue ₹79)

Issue

₹79

Listing

₹83

Current

₹80.26

+1.59% vs issue

Day range

₹79.5 – ₹87.15

As of 27 Feb 2026

IPO Timeline

Open Date

Feb 20

Close Date

Feb 24

Allotment

Feb 25

Listing

Feb 27

Price Band & Investment Details

Issue Size

20,886,200 shares
(aggregating up to ₹165.00 Cr)

Issue Price

₹75 – ₹79

Face Value

₹5/share

Market Lot

189 shares

Retail Min Investment

₹14,931

Listing At

NSE,BSE

Sale Type

both

Fresh Issue

11,392,500 shares
(aggregating up to ₹90 Cr)

Offer for Sale

9,493,700 shares
(aggregating up to ₹75 Cr)

Issue Type

book building

Gaudium IVF IPO IPO Grey Market Premium (GMP) - Live Rates & Current Status

Last updated: 1 day ago

Current GMP
₹-4
Previous GMP
₹-4

Gaudium IVF IPO IPO GMP Historical Data - Complete Track Record

Date IPO Issue Price (₹) GMP (₹) Est. Listing Price (₹) Est. Profit Amount (₹) Est. Profit % Last Updated
26 Feb 2026 Latest ₹79 ₹-4 ₹75 ₹-4
-5.06%
1:43 PM
25 Feb 2026 ₹79 ₹-4 ₹75 ₹-4
-5.06%
4:43 PM
24 Feb 2026 ₹79 ₹0 ₹79 ₹0
0%
4:46 PM
23 Feb 2026 ₹79 ₹5 ₹84 ₹5
6.33%
6:11 PM
22 Feb 2026 ₹79 ₹8.5 ₹87.5 ₹8.5
10.76%
11:18 AM
21 Feb 2026 ₹79 ₹8.5 ₹87.5 ₹8.5
10.76%
3:17 PM
20 Feb 2026 ₹79 ₹8 ₹87 ₹8
10.13%
1:29 PM
19 Feb 2026 ₹79 ₹8.5 ₹87.5 ₹8.5
10.76%
3:45 PM
18 Feb 2026 ₹79 ₹12 ₹91 ₹12
15.19%
6:07 PM
17 Feb 2026 ₹79 ₹15 ₹94 ₹15
18.99%
6:38 PM
16 Feb 2026 ₹79 ₹0 ₹79 ₹0
0%
10:42 AM
15 Feb 2026 ₹79 ₹0 ₹79 ₹0
0%
5:18 PM
14 Feb 2026 ₹79 ₹0 ₹79 ₹0
0%
7:00 PM

Subscription (Latest Snapshot)

View Detailed Subscription

Latest snapshot: Feb 24, 2026

Category Subscribed (x)
QIB 1.62x
NII 14.05x
bNII (bids above ₹10L) 12.71x
sNII (bids below ₹10L) 16.73x
Retail Investors 7.6x
Total 7.27x

Registrar

Registrar
Bigshare Services Private Limited
Registrar Phone
022-62638200
Registrar Email
ipo@bigshareonline.com
Registrar Address
Office No S6-2 6th Floor, Pinnacle Business Park, Mahakali Caves Rd, next to Ahura Centre, Andheri East Mumbai - 400093
Website
Visit Website

Promoter Holding

The Promoters of the company are Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna.

Promoter Holding Pre Issue
98.98%

Gaudium IVF IPO Investment Limits

IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.

Category Lots Shares Amount (₹)
Retail (Min) 1 189 ₹14,931
Retail (Max) 13 2,457 ₹194,103
S-HNI (Min) 14 2,646 ₹209,034
S-HNI (Max) 66 12,474 ₹985,446
B-HNI (Min) 67 12,663 ₹1,000,377

IPO Reservation

The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.

Category Shares Offered
QIB Shares Offered 10,443,100 (50.00%)
Anchor Investor Shares Offered
6,265,860 (30.00%)
QIB (Ex. Anchor) Shares Offered
4,177,240 (20.00%)
NII (HNI) Shares Offered 3,132,930 (15.00%)
bNII > ₹10L
2,088,620 (10.00%)
sNII < ₹10L
1,044,310 (5.00%)
Retail Shares Offered 7,310,170 (35.00%)
Total Shares Offered 20,886,200 (100.00%)

Gaudium IVF and Women Health Limited Overview

Gaudium IVF and Women Health Limited is a leading Indian healthcare provider specializing in advanced fertility treatments and women's health. Operating on a "Hub and Spoke" model, the company provides comprehensive IVF services including ICSI, egg freezing, and laparoscopy across 30+ locations in India. They aim to deliver "Motherhood Dreams" through high-quality clinical care and ethical medical practices.

Strengths:

  • Clinical Excellence: The company utilizes advanced medical technologies like Laminar Flow Hoods and Cryo Storage to ensure high success rates in IVF procedures.
  • Expert Leadership: Led by Dr. Manika Khanna, a pioneer in the field, the company benefits from a team of highly qualified doctors and embryologists.
  • Scalable Model: Their established "Hub and Spoke" infrastructure allows them to manage multiple centers efficiently while maintaining standardized care.
  • Robust Financials: The company has shown consistent profitability and a high Return on Net Worth (41.31% in FY25), indicating strong financial health.

Growth Strategy:

  • Geographic Expansion: A significant portion of IPO proceeds is dedicated to establishing new IVF centers in Tier-2 and Tier-3 cities where specialized fertility care is currently limited.
  • Service Diversification: Beyond IVF, the company is expanding into broader women’s health areas, including hormonal therapies and minimally invasive surgeries (laparoscopy).
  • Digital Reach: Increasing investments in digital marketing and awareness programs to educate Indian couples about fertility treatments and improve patient acquisition.

Gaudium IVF and Women Health Limited – Company Details, Address & Contact

Founded In
2015
Managing Director
Dr. Manika Khanna
Industry
Healthcare
Addresses
Registered Office B1/51, Janak Puri, B-1, New Delhi-110058, India.

Financial Summary (₹ in Crores)

Particulars FY 2023 FY 2024 FY 2025
Total Revenue 44.26 48.15 70.96
Profit After Tax (PAT) 13.53 10.32 19.13
EBITDA 20.07 19.27 28.63
Assets 36.63 51.01 88.51
Net Worth 22.73 26.99 46.3
Reserves & Surplus 21.74 26 15.6
Total Borrowing 9.78 15.73 18.93

Frequently Asked Questions

What are the Gaudium IVF IPO dates?

The Gaudium IVF IPO is expected to open in February, 2026, subject to SEBI approval. Final dates will be updated once announced officially.

What is the price band of Gaudium IVF IPO?

The price band for Gaudium IVF IPO is ₹75.00 - ₹79.00 per share.

What is the GMP today for Gaudium IVF IPO?

As per market sources, Gaudium IVF IPO GMP is currently ₹-4.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.

How much subscription has happened for Gaudium IVF IPO?

The subscription status for Gaudium IVF IPO stands at 7.27x overall.

When is the Gaudium IVF IPO listing date?

The listing date for Gaudium IVF IPO is February 27, 2026.

Community Discussion

0 Comments

No comments yet. Be the first to comment!

You may also like